GLENMARK PHARMGLENMARK PHARMGLENMARK PHARM

GLENMARK PHARM

No trades
See on Supercharts
Market capitalization
‪294.24 B‬INR
−25.20INR
‪2.97 B‬INR
‪129.90 B‬INR
‪138.38 M‬
Beta (1Y)
1.35

About GLENMARK PHARM

CEO
Glenn Mario Saldanha
Headquarters
Mumbai
Employees (FY)
‪14.97 K‬
Founded
1977
ISIN
INE935A01035
FIGI
BBG000BJ3VG6
Glenmark Pharmaceuticals Ltd. is a holding company, which engages in the development, manufacture, and marketing of pharmaceutical products. It operates through the India, North America, Latin America, Europe, and Rest of the World geographical segments. The company was founded by Gracias Saldanha on November 18, 1977 and is headquartered in Mumbai, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of GLENMARK is 1026.40 INR — it has decreased by 1.48% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange GLENMARK PHARM stocks are traded under the ticker GLENMARK.
GLENMARK PHARM is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
GLENMARK stock is 2.12% volatile and has beta coefficient of 1.35. Check out the list of the most volatile stocks — is GLENMARK PHARM there?
One year price forecast for GLENMARK PHARM has a max estimate of 1266.00 INR and a min estimate of 570.00 INR.
GLENMARK earnings for the last quarter are 6.90 INR per share, whereas the estimation was 11.16 INR resulting in a −38.17% surprise. The estimated earnings for the next quarter are 12.08 INR per share. See more details about GLENMARK PHARM earnings.
GLENMARK PHARM revenue for the last quarter amounts to ‪32.07 B‬ INR despite the estimated figure of ‪35.83 B‬ INR. In the next quarter revenue is expected to reach ‪35.01 B‬ INR.
Yes, you can track GLENMARK PHARM financials in yearly and quarterly reports right on TradingView.
GLENMARK stock has fallen by 1.62% compared to the previous week, the month change is a 12.07% rise, over the last year GLENMARK PHARM has showed a 100.47% increase.
GLENMARK net income for the last quarter is ‪−3.51 B‬ INR, while the quarter before that showed ‪−819.45 M‬ INR of net income which accounts for −328.79% change. Track more GLENMARK PHARM financial stats to get the full picture.
Today GLENMARK PHARM has the market capitalization of ‪294.24 B‬, it has increased by 5.05% over the last week.
Yes, GLENMARK dividends are paid annually. The last dividend per share was 2.50 INR. As of today, Dividend Yield (TTM)% is 0.24%. Tracking GLENMARK PHARM dividends might help you take more informed decisions.
GLENMARK PHARM dividend yield was 0.54% in 2022, and payout ratio reached 23.73%. The year before the numbers were 0.57% and 7.49% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, GLENMARK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GLENMARK PHARM stock right from TradingView charts — choose your broker and connect to your account.
GLENMARK reached its all-time high on Aug 21, 2015 with the price of 1262.90 INR, and its all-time low was 4.60 INR and was reached on Aug 13, 2001.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has ‪14.97 K‬ employees. See our rating of the largest employees — is GLENMARK PHARM on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GLENMARK PHARM technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GLENMARK PHARM stock shows the buy signal. See more of GLENMARK PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on GLENMARK PHARM future price: according to them, GLENMARK price has a max estimate of 1266.00 INR and a min estimate of 570.00 INR. Read a more detailed GLENMARK PHARM forecast: see what analysts think of GLENMARK PHARM and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GLENMARK PHARM EBITDA is ‪14.90 B‬ INR, and current EBITDA margin is 17.89%. See more stats in GLENMARK PHARM financial statements.